Literature DB >> 8327096

Treatment of intraventricular hemorrhage with tissue plasminogen activator.

J M Findlay1, M G Grace, B K Weir.   

Abstract

The patients with intraventricular hemorrhage (IVH) were treated with recombinant tissue plasminogen activator (rt-PA) injected directly into the lateral ventricles, followed by ventricular drainage. All had a decreased level of consciousness before treatment (Glasgow Coma Scale score 10 +/- 3.4). A total dose between 2 and 12 mg of rt-PA (6.4 +/- 3.3) was administered. For eight patients with aneurysmal IVH, treatment with rt-PA began with two patients the same day as the aneurysm clipping, and the day after with six patients. For a patient with an excision of a ruptured arteriovenous malformation and a patient with IVH resulting from a lateral ventricular catheterization during posterior fossa tumor surgery, treatment with rt-PA started 24 hours after surgery. After an injection of rt-PA, the ventricular drain was closed for 1 hour, followed by alternate-hourly drainage and intracranial pressure (ICP) monitoring. Five patients received a second injection of rt-PA on the second postoperative day, and one patient received a third dose on the third day. Among the eight patients given rt-PA the day after surgery, the volume of external cerebrospinal fluid (CSF) drainage for 24 +/- 8 hours before treatment was 61 +/- 57 ml, and the mean ICP was 22 +/- 5 mm Hg during this same time. Younger age and poorer neurological condition correlated with higher ICP before treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327096     DOI: 10.1227/00006123-199306000-00010

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  20 in total

1.  Intraventricular Hemorrhage in Adults.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-07       Impact factor: 3.598

Review 2.  Intraventricular fibrinolysis for intracerebral hemorrhage with severe ventricular involvement.

Authors:  Dimitre Staykov; Juergen Bardutzky; Hagen B Huttner; Stefan Schwab
Journal:  Neurocrit Care       Date:  2011-08       Impact factor: 3.210

3.  Intraventricular fibrinolysis for severe aneurysmal intraventricular hemorrhage: a randomized controlled trial and meta-analysis.

Authors:  Stephane Litrico; Fabien Almairac; Thomas Gaberel; Rohan Ramakrishna; Denys Fontaine; Jacques Sedat; Michel Lonjon; Philippe Paquis
Journal:  Neurosurg Rev       Date:  2013-05-02       Impact factor: 3.042

4.  Systemic hematologic status following intraventricular recombinant tissue-type plasminogen activator for intraventricular hemorrhage: the CLEAR IVH Study Group.

Authors:  Daniel B Herrick; Wendy C Ziai; Carol B Thompson; Karen Lane; Nichol A McBee; Daniel F Hanley
Journal:  Stroke       Date:  2011-09-22       Impact factor: 7.914

5.  Management of intraventricular hemorrhage.

Authors:  Holly E Hinson; Daniel F Hanley; Wendy C Ziai
Journal:  Curr Neurol Neurosci Rep       Date:  2010-03       Impact factor: 5.081

6.  Intraventricular hemorrhage secondary to intranidal aneurysm rupture-successful management by arteriovenous malformation embolization followed by intraventricular tissue plasminogen activator: case report.

Authors:  Glen A Pollock; Ali Shaibani; Issam Awad; H Hunt Batjer; Bernard R Bendok
Journal:  Neurosurgery       Date:  2011-02       Impact factor: 4.654

Review 7.  Thrombolytics in intraventricular hemorrhage.

Authors:  Paul Nyquist; Shannon LeDroux; Romergryko Geocadin
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

8.  [Treatment of intraventricular hemorrhage and hydrocephalus].

Authors:  H B Huttner; D Staykov; J Bardutzky; C Nimsky; G Richter; A Doerfler; S Schwab
Journal:  Nervenarzt       Date:  2008-12       Impact factor: 1.214

Review 9.  Alteplase. A reappraisal of its pharmacology and therapeutic use in vascular disorders other than acute myocardial infarction.

Authors:  A J Wagstaff; J C Gillis; K L Goa
Journal:  Drugs       Date:  1995-08       Impact factor: 9.546

10.  Massive intraventricular haemorrhage from aneurysmal rupture: patient proportions and eligibility for intraventricular fibrinolysis.

Authors:  Dennis J Nieuwkamp; Bon H Verweij; Gabriël J E Rinkel
Journal:  J Neurol       Date:  2009-10-13       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.